P

Inventor

SEITZ STEVEN P

US32 patents
⚠️ This page may combine multiple inventors who share the name “SEITZ STEVEN P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

17 patents
US9790169B2Oct 17, 2017

IDO inhibitors

BRISTOL MYERS SQUIBB CO19 citations91
US9822103B2Nov 21, 2017

Inhibitors of lysine methyl transferase

BRISTOL MYERS SQUIBB CO8 citations83
US9895330B2Feb 20, 2018

IDO inhibitors

BRISTOL MYERS SQUIBB CO2 citations73
US9738630B2Aug 22, 2017

Inhibitors of lysine methyl transferase

BRISTOL MYERS SQUIBB CO2 citations73
US9675571B2Jun 13, 2017

Inhibitors of indoleamine 2,3-dioxygenase (IDO)

BRISTOL MYERS SQUIBB CO6 citations73
US10959986B2Mar 30, 2021

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO3 citations72
US9758492B2Sep 12, 2017

IDO inhibitors

BRISTOL MYERS SQUIBB CO4 citations72
US10399932B2Sep 3, 2019

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

BRISTOL MYERS SQUIBB CO3 citations71
US10167254B2Jan 1, 2019

IDO inhibitors

BRISTOL MYERS SQUIBB CO1 citations71
US9765018B2Sep 19, 2017

IDO inhibitors

BRISTOL MYERS SQUIBB CO4 citations71
US11203592B2Dec 21, 2021

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO1 citations62
US7923556B2Apr 12, 2011

Phenyl-substituted pyrimidine compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO2 citations62
US12145927B2Nov 19, 2024

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO1 citations61
US11447449B2Sep 20, 2022

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO1 citations61
US11253525B2Feb 22, 2022

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO1 citations61
US12037323B2Jul 16, 2024

Uracil derivatives as Mer-AXL inhibitors

BRISTOL MYERS SQUIBB CO0 citations45
US7659281B2Feb 9, 2010

HMG-CoA reductase inhibitors

BRISTOL MYERS SQUIBB CO0 citations42

DU PONT MERCK PHARMA

5 patents

INNATE TUMOR IMMUNITY INC

3 patents

FLEXUS BIOSCIENCES INC

2 patents

RESEARCH CORP

2 patents

DU PONT PHARM CO

2 patents

MARKWALDER JAY A

1 patent